rs3087776

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001915.4(CYB561):​c.*1485G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.539 in 152,628 control chromosomes in the GnomAD database, including 23,413 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.54 ( 23340 hom., cov: 32)
Exomes 𝑓: 0.48 ( 73 hom. )

Consequence

CYB561
NM_001915.4 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.839

Publications

21 publications found
Variant links:
Genes affected
CYB561 (HGNC:2571): (cytochrome b561) Predicted to enable transmembrane monodehydroascorbate reductase activity. Predicted to be involved in ascorbate homeostasis. Predicted to be located in chromaffin granule membrane. Predicted to be active in lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2022]
CYB561 Gene-Disease associations (from GenCC):
  • orthostatic hypotension 2
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001915.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.7 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001915.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYB561
NM_001915.4
MANE Select
c.*1485G>A
3_prime_UTR
Exon 6 of 6NP_001906.3
CYB561
NM_001330421.2
c.*1485G>A
3_prime_UTR
Exon 6 of 6NP_001317350.1J3QRH5
CYB561
NM_001017916.2
c.*1485G>A
3_prime_UTR
Exon 6 of 6NP_001017916.1P49447-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYB561
ENST00000360793.8
TSL:1 MANE Select
c.*1485G>A
3_prime_UTR
Exon 6 of 6ENSP00000354028.3P49447-1
CYB561
ENST00000392975.6
TSL:1
c.*1485G>A
3_prime_UTR
Exon 6 of 6ENSP00000376701.2P49447-1
CYB561
ENST00000392976.5
TSL:3
c.*1485G>A
3_prime_UTR
Exon 6 of 6ENSP00000376702.1P49447-1

Frequencies

GnomAD3 genomes
AF:
0.540
AC:
81976
AN:
151938
Hom.:
23329
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.707
Gnomad AMI
AF:
0.596
Gnomad AMR
AF:
0.450
Gnomad ASJ
AF:
0.469
Gnomad EAS
AF:
0.153
Gnomad SAS
AF:
0.482
Gnomad FIN
AF:
0.537
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.496
Gnomad OTH
AF:
0.496
GnomAD4 exome
AF:
0.476
AC:
272
AN:
572
Hom.:
73
Cov.:
0
AF XY:
0.456
AC XY:
145
AN XY:
318
show subpopulations
African (AFR)
AF:
0.813
AC:
26
AN:
32
American (AMR)
AF:
0.500
AC:
9
AN:
18
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
7
AN:
20
East Asian (EAS)
AF:
0.167
AC:
7
AN:
42
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2
European-Finnish (FIN)
AF:
0.500
AC:
14
AN:
28
Middle Eastern (MID)
AF:
0.500
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
0.472
AC:
182
AN:
386
Other (OTH)
AF:
0.619
AC:
26
AN:
42
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.539
AC:
82023
AN:
152056
Hom.:
23340
Cov.:
32
AF XY:
0.535
AC XY:
39762
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.707
AC:
29304
AN:
41466
American (AMR)
AF:
0.450
AC:
6881
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.469
AC:
1629
AN:
3470
East Asian (EAS)
AF:
0.153
AC:
792
AN:
5174
South Asian (SAS)
AF:
0.483
AC:
2322
AN:
4812
European-Finnish (FIN)
AF:
0.537
AC:
5671
AN:
10558
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.496
AC:
33715
AN:
67972
Other (OTH)
AF:
0.491
AC:
1035
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1858
3717
5575
7434
9292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.499
Hom.:
24720
Bravo
AF:
0.536
Asia WGS
AF:
0.362
AC:
1262
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.63
DANN
Benign
0.41
PhyloP100
-0.84
Mutation Taster
=84/16
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3087776;
hg19: chr17-61510278;
COSMIC: COSV105260441;
COSMIC: COSV105260441;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.